(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIRIDIAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VIRIDIAN

ST13

US500000077766321

Class

35

Filing

77766321

Registration

4175944

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

54

Latest update

03/14/2023

Trademark type

Word

Nice classes

35

Filing date

06/23/2009

Registration date

07/17/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/14/2023

Last transaction

03/14/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/30/2009

First use in commerce

06/30/2009

Drawing code

4

Owner type

16

Owner location

Barnstable, MA

Examiner

RUTLAND, BARBARA

Law office

L10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Viridian Strategies, LLC
Viridian Strategies, LLC

Representatives

Margaret Ferguson LAW OFFICE OF MARGARET FERGUSON

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing business consulting services to drug companies and biotechnology companies to aid in the management of clinical trialsthe implementation of clinical trialsthe management of vendors involved in clinical trialsthe resolution of issues arising in clinical development programs; Regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Providing technical consulting services and information management servicesclinical data and regulatory submission management to medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval

Publications

History of USPTO decisions and trademark events.

54 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/14/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/14/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/14/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/14/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

08/26/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/17/2021

NA15

SEC. 15 ACKNOWLEDGEMENT - E-MAILED

12/03/2018

15AK

REGISTERED - SEC. 15 ACKNOWLEDGED

12/03/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/28/2018

E15R

TEAS SECTION 15 RECEIVED

10/30/2018

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

07/21/2018

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

07/21/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/21/2018

ES8R

TEAS SECTION 8 RECEIVED

07/14/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/14/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/17/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

07/17/2012

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/13/2012

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

06/12/2012

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/07/2012

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/06/2012

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/05/2012

EX3G

SOU EXTENSION 3 GRANTED

06/05/2012

IUAF

USE AMENDMENT FILED

05/01/2012

EXT3

SOU EXTENSION 3 FILED

05/01/2012

EEXT

SOU TEAS EXTENSION RECEIVED

05/01/2012

EISU

TEAS STATEMENT OF USE RECEIVED

05/01/2012

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/02/2011

EX2G

SOU EXTENSION 2 GRANTED

11/01/2011

EXT2

SOU EXTENSION 2 FILED

10/29/2011

EEXT

SOU TEAS EXTENSION RECEIVED

10/29/2011

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/21/2011

EX1G

SOU EXTENSION 1 GRANTED

04/20/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/20/2011

EXT1

SOU EXTENSION 1 FILED

04/15/2011

EEXT

SOU TEAS EXTENSION RECEIVED

04/15/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/02/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/07/2010

PUBO

PUBLISHED FOR OPPOSITION

09/07/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/31/2010

ALIE

ASSIGNED TO LIE

07/31/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/19/2010

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/14/2010

GNFR

FINAL REFUSAL E-MAILED

04/14/2010

CNFR

FINAL REFUSAL WRITTEN

04/14/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/24/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/23/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/23/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/25/2009

GNRT

NON-FINAL ACTION E-MAILED

09/25/2009

CNRT

NON-FINAL ACTION WRITTEN

09/25/2009

DOCK

ASSIGNED TO EXAMINER

09/21/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/26/2009

NWAP

NEW APPLICATION ENTERED

06/26/2009

Continuous trademark protection

Get notified about every new filing that threatens VIRIDIAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.